UCB gains two FDA drug approvals in one day

The latest stories trending on MedCity News.

Editor's Pick

Top Story In Same Day, UCB Lands Two FDA Drug Approvals in Autoimmune Diseases FDA approval of UCB's Bimzelx gives the Belgian drugmaker a contender in the crowded plaque psoriasis therapies market. In the rare disease generalized myasthenia gravis, the agency approved Zilbrysq, a UCB drug with advantages over two blockbuster AstraZeneca drugs addressing the same target. Sponsored Post US Prescription Drug Costs More Than Double Those in Canada Presented by MedCity News & Buy Canadian Insulin Increasingly, patients in the U.S. look to Canada for more affordable prescription options since the Canadian government regulates drug costs. Some companies have noticed and are beginning to capitalize on the demand. Read More. What are the strengths of decentralized clinical trials? "By bringing clinical trials to patients, DCTs have the power to solve for the enrollment challenges that plague standard trial design; save time and costs for pharma companies; and reach patients more equitably, allowing for more diverse trial populations and more thorough results." ~ Kwame Marfo, Head of Market Strategy and Innovation at Komodo Health Don't miss your opportunity to hear from Kwame and other knowledgable speakers at INVEST Digital Health on October 26th at Pegasus Park in Dallas. Register Today

Featured News

Hospitals Need to Cultivate a Culture of Informed Awareness In an upcoming webinar, learn how informed awareness can help hospitals overcome their most challenging operational challenges to simultaneously improve efficiency, staff engagement and satisfaction, quality of care, and profitability. Helping Doctors Help Patients: Digital Health's Role in Reinventing How the Work That is Healthcare is Delivered Investing in Friction-reducing tactics such as community building and providing benefits, training, and personalized support to employees will yield compounding long-term benefits while reducing churn rate. Report: Annual Family Premiums for Employer Coverage Increase 7% Annual family premiums for employer-sponsored coverage reached $23,968 in 2023, according to a new KFF survey. Of that family premium total, workers are contributing $6,575 annually. In Same Day, UCB Lands Two FDA Drug Approvals in Autoimmune Diseases FDA approval of UCB's Bimzelx gives the Belgian drugmaker a contender in the crowded plaque psoriasis therapies market. In the rare disease generalized myasthenia gravis, the agency approved Zilbrysq, a UCB drug with advantages over two blockbuster AstraZeneca drugs addressing the same target. Allara Snags $10M to Scale Its Platform for Women's Chronic Hormonal Conditions Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis. Amazon Starts Delivering Medications via Drone Amazon Pharmacy is now offering a drone delivery service for prescription medications in College Station, Texas. The service is free and allows patients to receive their medications within 60 minutes.

Resources

Achieve Full HIPAA Compliance With the Help of This Checklist With our free HIPAA checklist, you can effortlessly pinpoint your compliance status and identify any remaining steps needed to achieve full HIPAA compliance. Get started today and easily find out where you stand and what else needs to be done! Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe